Clinical Trial Update: A Study of SHR-A1811 and Fulvestrant, With or Without HS-10352, in Locally Advanced or Metastatic Breast Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial entry describes an early-phase study evaluating SHR-A1811 with Fulvestrant, with or without HS-10352, in locally advanced or metastatic brea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fulvestrant (fulvestrant)
• HS-10352
• SHR-A1811

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Breast Cancer, Locally Advanced or Metastatic Breast Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING